High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure: A Prospective Cohort Study

BACKGROUND: Early use of high-flow nasal cannula (HFNC) decreases the need for endotracheal intubation (EI) in different respiratory failure causes. While HFNC is used in coronavirus disease 2019 (COVID-19)-related acute hypoxemic respiratory failure (AHRF) under weak recommendations, its efficacy r...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshahrani, Mohammed S, Alshaqaq, Hassan M., Alhumaid, Jehan, Binammar, Ammar A., AlSalem, Khalid H, Alghamdi, Abdulazez, Abdulhady, Ahmed, Yehia, Moamen, AlSulaibikh, Amal, Al Jumaan, Mohammed, Albuli, Waleed H, Ibrahim, Talal, Yousef, Abdullah A., Almubarak, Yousef, Alhazzani, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474003/
https://www.ncbi.nlm.nih.gov/pubmed/34667467
http://dx.doi.org/10.4103/sjmms.sjmms_316_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474003/
https://www.ncbi.nlm.nih.gov/pubmed/34667467
http://dx.doi.org/10.4103/sjmms.sjmms_316_21

Ejemplares similares